& Sollott, S
Having megaloblastic anemia can make you more at risk of suffering from osteoporosis, problems with your vision, struggle with memory, worsened cognitive functioning, and if you were to become pregnant, it increases the risk of birth defects in the fetus
(2021) demonstrated that SCD-modeling Berk mice given the orally available PKR activator FT-4202 (etavopivat) for 2 weeks had significantly increased ATP and reduced 2,3-DPG, improved deformability, lower susceptibility to deoxygenation-induced sickling and rigidity, and attenuated indices of hemolysis
Cheng, D
Individual factors that influence appropriate dosing include body weight (some practitioners use 20-40 mg per kilogram of body weight as a guideline), overall health status, oxidative stress levels, and specific wellness goals
ChuJHWangHYeYChanPKPanSYFongWFet al